Effect of storage conditions on the stability of recombinant human MCP-1/CCL2

Abstract

Monocyte chemoattractant protein-1 (MCP-1) is commercially available in a form of recombinant protein. This makes it more convenient to study the functions of MCP-1 and its involvement in many cell functions. However, when using MCP-1 in experimental studies, if the analysis is not performed immediately, the stability of recombinant MCP-1 may become an issue. In this study, the stability of recombinant MCP-1 at different concentrations and storage conditions was investigated. Results show that no significant loss of MCP-1 is observed when MCP-1 solutions were stored at non-freezing condition (4°C) for seven days. However, for storage at freezing conditions (−20°C or −81°C), it appears that the first freeze-thaw cycle may contribute to some loss of MCP-1 in the solutions, and such loss may be concentration and time dependent. The effect of multiple freeze-thaw cycles for storage at freezing conditions was also examined. Data reveal that the second freeze-thaw cycle causes approximately 50% loss of MCP-1 in the solutions. This finding confirms that multiple freeze-thaw cycles should be avoided. The findings of this study provide an outline of how storage can affect the stability of recombinant proteins and should be taken into account during the evaluation of the concentration of recombinant proteins.

Cytokine concentrations are related to level of mental distress in inpatients not using anti-inflammatory drugs

“…We investigated cytokine IL-1RA and chemokine MCP-1 due to their robustness and very high detectability, a finding in line with other studies (Leemasawatdigul & Gappa-Fahlenkamp, 2011;Holub et al, 2013). Also, these cytokines had fewer than 6% below LOD.…”

Lithium ameliorates tubule-interstitial injury through activation of the mTORC2/protein kinase B pathway

“…In agreement with this view, it was observed that lithium treatment decrease M2-subtype macrophages induced by albumin overload (BSA+LIT group) and increased M1-subtype macrophages when the animals were treated only with lithium (LIT group). Interestingly, in isolated human macrophages, it was observed that lithium induces the activation of a CCL2 and tumor necrosis factor α secreting subtype macrophage [49–51]. These results together point out a possible role of lithium in modulating macrophage polarization, but further experiments are necessary to clarify this issue.…”

Regulation of Macrophage Biology by Lithium: A New Look at an Old Drug

“…However, there was no decrease in CCL2 levels (similar to mRNA expression) likely because LiCl pretreatment itself induced maximal secretion into the culture supernatants prior to LPS treatment and further LPS treatment likely was not able to decrease this level in the culture supernatant. Note that the secreted CCL2 in the cell culture supernatant is also likely quite stable (Leemasawatdigul and Gappa-Fahlenkamp, 2011) with in the time points that we examined. Taken together, our results demonstrate differential effects of LiCl on Ccl2 expression in the absence and presence of LPS and further suggest that these observations are likely independent of its effects on GSK3β.…”